AseBio
Registrarse
Registrarse
Registrarse

NANBIOSIS-ICTS

www.nanbiosis.es/Valencia, España

Acerca de

We cover the entire life cycle of biomedical device development, from design to preclinical validation in both large and small animals. We offer comprehensive solutions to research challenges through our “Cutting-Edge Biomedical Solutions” (CEBS).

The Spanish Strategy for Science, Technology and Innovation includes the “National Scientific and Technological Infrastructure Map (ICTS)”. These ICTS are large installations, resources, facilities and services, unique in its kind, that are dedicated to cutting edge and high quality research and technological development, as well as to promote exchange, transmission and preservation of knowledge, technology transfer and innovation. These are facilities of different scientific areas distributed throughout the Spanish territory and are OPEN to competitive access to users of the whole research community in the public and private sector. NANBIOSIS inclusion in the Map of ICTS was recognized by the Spanish Government in 2014 and periodically renewed till now.

NANBIOSIS is managed under the ISO9001 certification for standard quality control system

Redes sociales

Ámbitos de aplicación

Biotecnología SanitariaServicios profesionales y de I+D

Biotecnología Sanitaria: Áreas de actividad

Biofármacos/BiomarcadoresCélulas madre/Cultivos celulares/Mantenimiento de cultivos celularesTerapia tisular y biomaterialesDiagnóstico in vitro/por imagen/Dispositivos medicosDrug delivery/Drug development/Drug Discovery/ScreeningOtros

Servicios de I+D

BioinformáticaDesarrollo de kits biotecnológicosEmpresas CRO / CMO / SMOGenómicaNanotecnologías y biología in silicoProteómicaOtros

Biotecnología Agroalimentaria: Alimentación

Detección de sustanciasSeguridad alimentariaOtros

Biotecnología Sanitaria: Áreas terapéuticas

Enfermedades cardiovasculares y sistema circulatorioEnfermedades infecciosas/genéticas y rarasEnfermedades InflamatoriasInmunologíaOncologíaOftalmología y optometríaSistema respiratorio y pulmonarOtros

Biotecnología Industrial: Áreas de actividad

EnzimasOtros

Biotecnología Agroalimentaria: Agricultura/Veterinaria/Medio ambiente

Salud animal / Veterinaria

Servicios profesionales

Otros

Representantes

Communication Manager

NANBIOSIS-ICTS

Marketplace (14)

  • Capacidades de investigación y tecnológicas

    Anti-peptide antibodies

    Efficiently develop anti-peptide antibodies for precise protein targeting and post-translational modification detection.

    • Oncología
    • Inmunología
    • Detección de sustancias
    • Enfermedades infecciosas
    • Salud animal/Veterinaria
    Autor

    Communication Manager en NANBIOSIS-ICTS

    Zaragoza, España

  • Capacidades de investigación y tecnológicas

    Protein-only nanomaterial platforms

    Revolutionizing healthcare with recombinant proteins — unleashing safe, targeted drug delivery and tissue regeneration for groundbreaking therapeutic treatments.

    • Oncología
    • Inmunología
    • Enfermedades genéticas y raras
    Autor

    Communication Manager en NANBIOSIS-ICTS

    Zaragoza, España

  • Capacidades de investigación y tecnológicas

    Proteomics: recombinant protein production, purification and characterization

    This brand new Cutting Edge Biomedical Solution allows you to obtain customized recombinant proteins and a wide proteomic characterization.

    • Enzimas
    • Enfermedades infecciosas
    • Sistema respiratorio y pulmonar
    Autor

    Communication Manager en NANBIOSIS-ICTS

    Zaragoza, España

  • Capacidades de investigación y tecnológicas

    Peptides for biomedical applications in animal models

    Custom synthesis of peptides and in vivo validation to revolutionize nanomedicine with precision drug delivery.

    • Enzimas
    • Oncología
    • Sistema nervioso central
    • Enfermedades genéticas y raras
    Autor

    Communication Manager en NANBIOSIS-ICTS

    Zaragoza, España

  • Capacidades de investigación y tecnológicas

    Biofunctionalized Nanoconjugates: Design, Production, and Characterization

    Integrated service to create and optimize antibody-functionalized nanoconjugates for reliable diagnostics and nanomedicine.

    • Detección de sustancias
    • Sistema nervioso central
    • Sangre y sistema linfático
    • Enfermedades cardiovasculares y sistema circulatorio
    Autor

    Communication Manager en NANBIOSIS-ICTS

    Zaragoza, España

  • Capacidades de investigación y tecnológicas

    Physicochemical Characterization of Nanomedicines

    Fast-track nanotherapeutics to market with NANBIOSIS – expert characterization studies tailored for nanomedicines ensure rapid regulatory approval.

    • Enzimas
    • Detección de sustancias
    • Enfermedades infecciosas
    • Sistema nervioso central
    Autor

    Communication Manager en NANBIOSIS-ICTS

    Zaragoza, España

  • Capacidades de investigación y tecnológicas

    In vitro Characterization of Nanomedicines

    Accelerate your nanomedicine’s journey to market with NANBIOSIS: tailored in vitro characterization services ensuring preclinical validation success, saving crucial time in the development process.

    • Inmunología
    • Enfermedades infecciosas
    Autor

    Communication Manager en NANBIOSIS-ICTS

    Zaragoza, España

  • Capacidades de investigación y tecnológicas

    In vivo Characterization of Nanomedicines

    Fast-track your nanomedicine’s path to market with NANBIOSIS: tailored preclinical studies, cutting-edge imaging, and comprehensive analytics, all while ensuring ethical compliance and regulatory adherence.

    • Oncología
    • Inmunología
    • Enfermedades infecciosas
    • Sistema digestivo y hepatología
    • Enfermedades cardiovasculares y sistema circulatorio
    Autor

    Communication Manager en NANBIOSIS-ICTS

    Zaragoza, España

  • Capacidades de investigación y tecnológicas

    Nanoparticles with antimicrobial properties

    Design advanced antimicrobial nanoparticles for comprehensive, affordable wound treatment, addressing multiple aspects of infection with enhanced effectiveness.

    • Microorganismos
    • Seguridad alimentaria
    • Enfermedades infecciosas
    • Fermentación/Biocatálisis
    Autor

    Communication Manager en NANBIOSIS-ICTS

    Zaragoza, España

  • Capacidades de investigación y tecnológicas

    Enzyme-loaded nanovesicles

    Revolutionize disease treatment with our new Cutting-Edge Solution — precise enzyme-loaded nanovesicles, offering targeted therapies for various disorders with optimal efficacy and safety.

    • Enzimas
    • Inmunología
    • Enfermedades inflamatorias
    • Enfermedades genéticas y raras
    • Trastornos metabólicos y endocrinología
    Autor

    Communication Manager en NANBIOSIS-ICTS

    Zaragoza, España

  • Capacidades de investigación y tecnológicas

    Peptide-functionalized nanoparticles

    Precision Delivery, Tailored Solutions: Peptide-Functionalized Nanoparticles for Next-Generation Therapies.

    • Inmunología
    • Desórdenes musculoesqueléticos
    • Enfermedades genéticas y raras
    Autor

    Communication Manager en NANBIOSIS-ICTS

    Zaragoza, España

  • Capacidades de investigación y tecnológicas

    Aerosolized formulations for pulmonary administration

    End-to-end development and characterization of advanced aerosol formulations for precise and effective pulmonary drug delivery.

    • Enfermedades infecciosas
    • Sistema respiratorio y pulmonar
    Autor

    Communication Manager en NANBIOSIS-ICTS

    Zaragoza, España

  • Capacidades de investigación y tecnológicas

    Biomedical devices and antimicrobial properties

    Enhance the safety and efficacy of your biomedical device by evaluating its antimicrobial properties and behavior in realistic physiological environments.

    • Microorganismos
    • Detección de sustancias
    • Enfermedades infecciosas
    Autor

    Communication Manager en NANBIOSIS-ICTS

    Zaragoza, España

  • Capacidades de investigación y tecnológicas

    Scaffolds for tissue engineering and regeneration by 3D bioprinting

    Develop and validate customized 3D-bioprinted scaffolds with in vivo models, bridging advanced biomaterials research and real-world regenerative medicine applications.

    • Enfermedades infecciosas
    • Desórdenes musculoesqueléticos
    Autor

    Communication Manager en NANBIOSIS-ICTS

    Zaragoza, España